Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Daphne Day"'
Autor:
Genevieve Dall, Karen Harris, Nonie Chan, Stephen J. Luen, Sophia Frentzas, Daphne Day, Michelle Barrett, Anna Kilgour, Mark Buzza
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4519-4530 (2024)
The Victorian Precision Oncology Summit, convened in 2023, was a joint initiative between the Victorian Comprehensive Cancer Centre Alliance (VCCC Alliance) and the Monash Partners Comprehensive Cancer Consortium (MPCCC) and was proposed to guide a c
Externí odkaz:
https://doaj.org/article/925a83d307a64d109d6bb755f122a7ca
Autor:
Alberto Hernando‐Calvo, Eoghan Malone, Daphne Day, Amy Prawira, Ilan Weinreb, S. Y. Cindy Yang, Horace Wong, Angela Rodriguez, Sarah Jennings, Anneli Eliason, Lisa Wang, Anna Spreafico, Lillian L. Siu, Aaron R. Hansen
Publikováno v:
Cancer Medicine, Vol 12, Iss 20, Pp 20299-20310 (2023)
Abstract Objectives We aimed to evaluate the activity of selinexor, an oral selective inhibitor of nuclear export, in patients with recurrent or metastatic salivary gland tumors (SGT). Methods GEMS‐001 is an open‐label Phase 2 study for patients
Externí odkaz:
https://doaj.org/article/efef56b21f914e1590723168e744ce08
Autor:
Holly Wang, Lisa Grech, Jennifer Wong, David Hoffman, Barbora de Courten, Brett Sillars, Mark Savage, Alastair Kwok, Mike Nguyen, Nathan Bain, Daphne Day, Eva Segelov, on behalf of the DIABVACCS Investigators
Publikováno v:
Vaccines, Vol 12, Iss 6, p 662 (2024)
Background: This study explored vaccination hesitancy, diabetes-specific COVID-19 vaccination concerns, and whether they predicted vaccination uptake in people with diabetes. Methods: Quantitative, cross-sectional, and predictive approaches were used
Externí odkaz:
https://doaj.org/article/92e234c7c9c04281837848683c5495e9
Autor:
Daphne Day, Han Chong Toh, Raghib Ali, Estelle Mei Jye Foo, John Simes, John Whay Kuang Chia, Eva Segelov
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEThe Asia-Pacific (APAC) region is a major focus for multinational clinical trials, although its cultural, linguistic, economic, and regulatory diversity pose significant challenges for trial conduct, particularly for academic clinical trials.M
Externí odkaz:
https://doaj.org/article/d2e76334fda04eb9bb292a3b55e61b90
Autor:
Hui Li, Mark Voskoboynik, Qing Zhou, Hongming Pan, Juan Zhang, Yi-Long Wu, Bo Gao, Jun Zhao, Yunpeng Liu, Qian Chu, Lifeng Wang, Jiuwei Cui, Daphne Day, Xinmin Yu, Dingzhi Huang, Zhiyong Ma, Meili Sun, Jingxun Wu, Zhehai Wang, Yanyan Peng
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 2 (2023)
Background Some patients with locally advanced/metastatic non-small cell lung cancer (NSCLC) respond poorly to anti-programmed cell death protein 1 (PD-1)/anti-programmed death-ligand 1 (PD-L1) treatments. Combination with other agents may improve th
Externí odkaz:
https://doaj.org/article/fd315c6599db4662b7edb691c3c4f5da
Autor:
Christy Ralph, Sumati Gupta, Matthew Zibelman, Brendan D Curti, Kevin J Harrington, Steven J O'Day, Andrew G Hill, David C Campbell, Gavin M Wright, David E Gerber, Jonathan E Rosenberg, Jaime R Merchan, Charles M Rudin, Hardev S Pandha, Wallace L Akerley, Daphne Day, Timothy D Clay, Ross R Jennens, Yixin Ren, Emmett V Schmidt, Lisa Guttman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Background Oncolytic virus V937 showed activity and safety with intratumoral administration. This phase 1 study evaluated intravenous V937±pembrolizumab in patients with advanced solid tumors.Methods Patients had advanced non-small cell lung cancer
Externí odkaz:
https://doaj.org/article/07dff5f507bc4d64bce5f819f24c264d
Publikováno v:
Clinical Case Reports, Vol 9, Iss 3, Pp 1350-1353 (2021)
Abstract We report a case of synchronous p16+ SCC involving both the nasopharynx and base of tongue treated with definitive chemo‐radiotherapy with concurrent high dose cisplatin. The nasopharyngeal lesion was detected incidentally on PET/CT imagin
Externí odkaz:
https://doaj.org/article/a9f73953bf814b67b31c5e4de6617b92
Autor:
Eva Segelov, Hans Prenen, Daphne Day, C. Raina Macintyre, Estelle Mei Jye Foo, Raghib Ali, Quanyi Wang, Xiaoting Wei, Gilberto de Lima Lopes, Kefeng Ding, Gong Chen, John Whay Kuang Chia, Han Chong Toh
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 585-588 (2020)
Externí odkaz:
https://doaj.org/article/54db7ec56ed34fa699baf42e80a421a6
Autor:
Siddharth Menon, Amy Davies, Sophia Frentzas, Cheryl‐Ann Hawkins, Eva Segelov, Daphne Day, Ben Markman
Publikováno v:
Cancer Reports, Vol 5, Iss 2, Pp n/a-n/a (2022)
Abstract Background With the rapid influx of novel anti‐cancer agents, phase I clinical trials in oncology are evolving. Historically, response rates on early phase trials have been modest with the clinical benefit and ethics of enrolment debated.
Externí odkaz:
https://doaj.org/article/78eae5c9830d41b9a993510cdf6bab8c
Autor:
Tammie Choi, Bryan Chan, Lisa Grech, Alastair Kwok, Kate Webber, Jennifer Wong, Mike Nguyen, Nathan Bain, Daphne Day, Amelia McCartney, Ruby Hamer, Eva Segelov, on behalf of the CANVACCS DIABVACCS and MSVACCS Investigators
Publikováno v:
Vaccines, Vol 11, Iss 2, p 239 (2023)
Background: People with chronic illnesses have increased morbidity and mortality associated with COVID-19 infection. The influence of a person’s serious and/or comorbid chronic illness on COVID-19 vaccine uptake is not well understood. Aim: To unde
Externí odkaz:
https://doaj.org/article/c27398b9c0d94074a09e94105800da42